Pesquisas alternativas:
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level catheter (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), levels other (Expandir a Pesquisa), level three (Expandir a Pesquisa)
novel thr » novel thrb (Expandir a Pesquisa), novel ther (Expandir a Pesquisa), novel th2 (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de novel » de novela (Expandir a Pesquisa), de nove (Expandir a Pesquisa), de novelas (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level catheter (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), levels other (Expandir a Pesquisa), level three (Expandir a Pesquisa)
novel thr » novel thrb (Expandir a Pesquisa), novel ther (Expandir a Pesquisa), novel th2 (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de novel » de novela (Expandir a Pesquisa), de nove (Expandir a Pesquisa), de novelas (Expandir a Pesquisa)
de level » de leval (Expandir a Pesquisa), de leve (Expandir a Pesquisa), de leves (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
1
“... by the pineal gland and enterochromaffin cells which control sleep and gastrointestinal motility. Low levels...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Simsek, Melek, Meijer, Berrie, Mulder, Chris J. J., van Bodegraven, Adriaan A., de Boer, Nanne K. H.
Publicado no Ther Drug Monit (2017)
“.... In the current therapeutic drug monitoring, metabolite levels are assessed in erythrocytes, whereas leukocytes...”Publicado no Ther Drug Monit (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... levels, and σ-1 receptor binding and modulation). These additional functions of pridopidine suggest...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)
“... antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib...”Publicado no Rheumatol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis...
Por de Welzen, Lynne, Eldholm, Vegard, Maharaj, Kashmeel, Manson, Abigail L., Earl, Ashlee M., Pym, Alexander S.
Publicado no Antimicrob Agents Chemother (2017)
“...Genetics-based drug susceptibility testing has improved the diagnosis of drug-resistant...”Publicado no Antimicrob Agents Chemother (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Rezende, Vinicius Marcondes, Rivellis, Ariane, Novaes, Mafalda Megumi Yoshinaga, de Alencar Fisher Chamone, Dalton, Bendit, Israel
Publicado em 2013
“... standard for monitoring patients, and imatinib blood levels have also become an important tool...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Salviato Balbão, Marina, Cecílio Hallak, Jaime Eduardo, Arcoverde Nunes, Emerson, Homem de Mello, Mauricio, Triffoni-Melo, Andresa de Toledo, Ferreira, Flavia Isaura de Santi, Chaves, Cristiano, Durão, Ana Maria Sertori, Ramos, Adriana Pelegrino Pinho, de Souza Crippa, José Alexandre, Queiroz, Regina Helena Costa
Publicado em 2014
“...OBJECTIVE: Olanzapine is an atypical antipsychotic drug used to treat schizophrenia. Some...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Saint-Léger, Adélaïde, Sinadinos, Christopher, Ribas de Pouplana, Lluís
Publicado no Bioengineered (2016)
“... provide useful guidelines to facilitate the development of novel drug candidates which are more potent...”Publicado no Bioengineered (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Vo, Pamela, Paris, Nicolas, Bilitou, Aikaterini, Valena, Tomas, Fang, Juanzhi, Naujoks, Christel, Cameron, Ann, de Reydet de Vulpillieres, Frederic, Cadiou, Francois
Publicado no Neurol Ther (2018)
“... commonly reported to have at least moderate to severe levels of pain, corresponding to the inability...”Publicado no Neurol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Castle, Jessica R., DeVries, J. Hans, Kovatchev, Boris
Publicado no Diabetes Technol Ther (2017)
“... Food and Drug Administration approval, and more systems are likely to follow. As the field of AID...”Publicado no Diabetes Technol Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado no Oncologist (2017)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Andrés-Guerrero, Vanessa, Perucho-González, Lucía, García-Feijoo, Julián, Morales-Fernández, Laura, Saenz-Francés, Federico, Herrero-Vanrell, Rocío, Júlvez, Luis Pablo, Llorens, Vicente Polo, Martínez-de-la-Casa, José María, Konstas, Anastasios-Georgios P.
Publicado no Adv Ther (2016)
“... levels. In this article we review current perspectives on the use of anti-VEGF drugs as adjuvant therapy...”Publicado no Adv Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... of primary cancer, tumor stage, treatment selection, serum levels of glutamic-pyruvic transaminase, albumin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Ho, Pui Yan, Duan, Zhijian, Batra, Neelu, Jilek, Joseph L., Tu, Mei-Juan, Qiu, Jing-Xin, Hu, Zihua, Wun, Theodore, Lara, Primo N., DeVere White, Ralph W., Chen, Hong-Wu, Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2018)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... could be based on an "all or none" detection of the marker rather than on drug levels....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Costa, Pedro M, Cardoso, Ana L, Mendonça, Liliana S, Serani, Angelo, Custódia, Carlos, Conceição, Mariana, Simões, Sérgio, Moreira, João N, Pereira de Almeida, Luís, Pedroso de Lima, Maria C
Publicado em 2013
“... cells resulted in increased levels of the tumor suppressors PTEN and PDCD4, caspase 3/7 activation...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Giles, Kurt, Berry, David B., Condello, Carlo, Hawley, Ronald C., Gallardo-Godoy, Alejandra, Bryant, Clifford, Oehler, Abby, Elepano, Manuel, Bhardwaj, Sumita, Patel, Smita, Silber, B. Michael, Guan, Shenheng, DeArmond, Stephen J., Renslo, Adam R., Prusiner, Stanley B.
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Hassan, Amin S, Nabwera, Helen M, Mwaringa, Shalton M, Obonyo, Clare A, Sanders, Eduard J, Rinke de Wit, Tobias F, Cane, Patricia A, Berkley, James A
Publicado em 2014
“...) and acquired drug resistance (ADR) may negatively affect these gains. This study describes the prevalence...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por de Brito, Monique Araújo, Rodrigues, Carlos Rangel, Cirino, José Jair Viana, Araújo, Jocley Queiroz, Honório, Thiago, Cabral, Lúcio Mendes, de Alencastro, Ricardo Bicca, Castro, Helena Carla, Albuquerque, Magaly Girão
Publicado no Molecules (2012)
“... for the design of novel NNRTIs with improved potency and increased ability to avoid the development of drug...”Publicado no Molecules (2012)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por de Bandt, Michel, Fautrel, Bruno, Maillefert, Jean Francis, Berthelot, Jean Marie, Combe, Bernard, Flipo, René-Marc, Lioté, Frédéric, Meyer, Olivier, Saraux, Alain, Wendling, Daniel, Le Loët, Xavier, Guillemin, Francis
Publicado em 2009
“... antirheumatic drug (DMARD) treatment in rheumatoid arthritis patients, based on expert opinion. METHODS: Nine...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo